Zantac Recall: FDA Recommends Ranitidine Removed From Shelves
« Back to Blog

Zantac Recall: FDA Recommends Ranitidine Removed From Shelves

Cincinnati, Ohio Drug Injury lawyer and Pharmaceutical Recall Lawyer reviewing the FDA Zantac Recall and cancer cases related to Zantac


FDA Zantac Recall


The FDA (Food and Drug Administration) has asked companies to halt sales of Zantac and all forms of ranitidine products. The safety agency has concluded that the heartburn drug may contain potentially cancer-causing contaminants.

The FDA has also recommended in their Zantac Recall statement for consumers stop using Zantac and other over-the-counter ranitidine products. Patients who rely on heartburn medications should contact their doctors about an alternative.

Most manufacturers and some retailers took these products off the shelf long before the official FDA Zantac recall. Pharmacy chains like Walgreens, Rite Aid and CVS stopped selling Zantac months ago.

Joe Lyon is a Cincinnati, Ohio drug recall lawyer taking cancer diagnosis cases related to the use of Zantac and other Heartburn drugs.


Heartburn Drug Cancer Cases


As early as September, 2019, the FDA announced that a cancer-causing contaminant called N-nitrosodimethylamine, or NDMA, was found in some Zantac pills and other ranitidine medications. Sanofi, the manufacturer of Zantac, recalled the product in October.

NDMA is a probable human carcinogen. In 2019, the FDA became aware of independent laboratory testing that found NDMA in ranitidine. These levels would not be normally expected to lead to an increase in the risk of cancer. However, a sustained higher level of drug exposure may increase the risk of cancer in humans.

The F.D.A now says, “the impurity in some ranitidine products increases over time and when stored at higher than room temperatures and may result in consumer exposure to unacceptable levels of this impurity.” The long-term effects of Zantac use could include:

  • Bladder cancer
  • Colon cancer
  • Rectal cancer
  • Esophageal cancer
  • Intestinal cancer
  • Kidney cancer
  • Liver cancer
  • Ovarian cancer
  • Pancreatic cancer
  • Prostate cancer
  • Stomach cancer
  • Testicular cancer
  • Thyroid cancer
  • Uterine Cancer

The Lyon Firm has experience engaging large pharmaceutical firms in litigation following drug injuries. American consumers have a right to know medication risks, and when companies fail to properly test their products and fail to warn consumers of adverse health effects, legal action may be the best way forward to hold a company accountable.

Call 800.513.2403 for a free consultation, and to discuss the repercussions of the recent FDA Zantac recall.

Contact us today.

%d bloggers like this: